For more than a decade, companies in the financial services industry have favored online workspaces (also known as virtual datarooms or virtual dealrooms) over time intensive, costly paper-based dealrooms for mergers and acquisitions and loan syndication transactions. In recent years, other industries have discovered the numerous benefits an online workspace provides for managing access to critical and sensitive information, and safeguarding against increased security and compliance risks.

Since 1997, more than 750,000 users representing over 90,000 organizations worldwide have used our On-Demand Workspaces™ to safeguard documents, streamline communication and collaborate on thousands of projects and deals. As the leader in the online workspace market, we feel our success is attributed to our unwavering commitment to delivering quality solutions and best-in-class client service, while being dedicated to client satisfaction.

As President of Estabrook Ventures, Tom provides interim management services, business plan development and angel investments to medical companies. Mr. Farb was President & Chief Operating Officer of Indevus Pharmaceuticals, an $80 million developer and marketer of pharmaceuticals and medical devices, where he utilized its 100 person sales force to sell drugs and devices. From 1998 to 2006, Mr. Farb co-founded New America Partners a Boston - Shanghai based private equity firm and led investments in China including WuXi Pharmatechs and a joint venture fund with the City of Shanghai.  Previously, Mr. Farb was General Partner / Chief Financial Officer at Summit Partners and held executive positions with Interneuron Pharmaceutics and Cytyc Corp. Mr. Farb graduated with a B.A. from Harvard College.

Bob Feldman has been helping small to medium size advanced technology companies improve sales and marketing results for over 25 years.  Past clients represent a wide variety of technologies ranging from supercomputers to middleware, storage, environmental services, data mining, development tools and product testing with firms such as Etnus TotalView, Inventu, Pine and Swallow Environmental, HP, Intel, National Semiconductor, Iona, Thinking Machines, Sequent/IBM and Lucent. Bob has been honored with an Emmy Nomination for broadcast TV, four Telly Awards for industrial media, and a White House Assistantship for writing. He holds a BA in Communications and a Masters in Research Design. 

John Santini is an entrepreneur with over a decade of experience in drug delivery and biosensing. Under his leadership, MicroCHIPS has attracted top tier venture capital and corporate investors, demonstrated the first implantable drug delivery microchip, and is developing an implantable sensor for diabetes management based on its proprietary reservoir array technology. He is a recognized expert in the application of microtechnology in healthcare and has over 60 issued/pending patents. Dr. Santini was recently honored as one of Popular Science Magazine’s Brilliant Ten and one of the Top 100 Young Innovators in the world by Technology Review Magazine. He obtained his PhD in chemical engineering from MIT as a National Science Foundation Fellow.

Tim joined Cyberkinetics in 2003 from Haemonetics Corporation, a medical device company located in Braintree, MA where he was Executive Vice President with responsibility for business development and global marketing. From 1994 -1999, Mr. Surgenor was President of Genzyme Tissue Repair, the cell therapy division of Genzyme Corporation. Previously, Mr. Surgenor was Executive Vice President and Chief Financial Officer of BioSurface Technology, Inc. and also held various positions in operations at Integrated Genetics. Mr. Surgenor received a B.A. in Biochemistry from Williams College and an M.B.A. from Harvard Business School.